Pokeweed Antiviral Inhibits HIV
WESTPORT, Conn-Researchers from the Parker Hughes Institute in St. Paul, Minn, have found that pokeweed antiviral protein (PAP) inhibits HIV-1without injuring sperm or female genital tract epithelial cells.
The nonspermicidal antiretroviral treatment could allow pregnancy of women in couples where the male partner is HIV-positive without putting the mother and fetus at risk of contracting the viral infection.
PAP comes from purified leaves of Phytolacca Americana and has shown broad antiviral activity against a number of pathogenic viruses. It has shown to protect against HIV-1, herpes simplex virus, and cytomegalovirus.
The discovery is important because it is a potent antiviral agent that has no adverse effects on either sperm function or female genital-tract epithelial cells, making it a fitting ingredient for spermicides.
PAP is said to directly inactivate the virus as well as interrupt the virus life cycle under conditions that do not affect sperm function.
Information from: www.hivandhepatitis.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
